1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 HIV: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports

3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.3.1 Total Prevalence of HIV
3.3.2 Diagnosed Prevalence of HIV
3.3.3 Diagnosed Incidence of HIV
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Sources Not Used
3.4.3 Forecast Assumptions and Methods
3.4.4 Total Prevalent Cases of HIV
3.4.5 Diagnosed Prevalent Cases of HIV
3.4.6 Diagnosed Prevalent Cases of HIV with HBV/HCV Coinfection
3.4.7 Diagnosed Prevalent Cases of HIV on ART
3.4.8 Diagnosed Incident Cases of HIV
3.4.9 Prophylactic Population on PrEP
3.5 Epidemiological Forecast for HIV (2019-2029)
3.5.1 Total Prevalent Cases of HIV
3.5.2 Diagnosed Prevalent Cases of HIV
3.5.3 Age-Specific Diagnosed Prevalent Cases of HIV
3.5.4 Sex-Specific Diagnosed Prevalent Cases of HIV
3.5.5 Diagnosed Prevalent Cases of HIV with Coinfection
3.5.6 Diagnosed Prevalent Cases of HIV on ART
3.5.7 Diagnosed Incident Cases of HIV
3.5.8 Age-Specific Diagnosed Incident Cases of HIV
3.5.9 Sex-Specific Diagnosed Incident Cases of HIV
3.5.10 Prophylactic Population on PrEP
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 COVID-19 Impact
3.6.3 Limitations of the Analysis
3.6.4 Strengths of the Analysis

4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Summary of Newly Added Data Types
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for HIV

List of Figures
Figure 1: 7MM, Total Prevalent Cases of HIV, Men and Women, All Ages, 2019 and 2029 (N)
Figure 2: 7MM, Diagnosed Prevalent Cases of HIV, Men and Women, All Ages, 2019 and 2029 (N)
Figure 3: 7MM, Diagnosed Incident Cases of HIV, Men and Women, All Ages, 2019 and 2029 (N)
Figure 4: 7MM, Total Prevalence of HIV, Men and Women, All Ages, 2009-2029 (%)
Figure 5: 7MM, Diagnosed Prevalence of HIV, Men and Women, All Ages, 2009-2029 (%)
Figure 6: 7MM, Diagnosed Incidence of HIV, Men and Women, All Ages, 2009-2029 (Cases per 100,000 Population)
Figure 7: Sources Used for Total Prevalent Cases of HIV
Figure 8: Sources Used for Diagnosed Prevalent Cases of HIV
Figure 9: Sources Used for Diagnosed Prevalent Cases of HIV Coinfected with HBV or HCV
Figure 10: Sources Used for Diagnosed Prevalent Cases of HIV on ART
Figure 11: Sources Used for Diagnosed Incident Cases of HIV
Figure 12: Sources Used for the Prophylactic Population on PrEP
Figure 13: 7MM, Total Prevalent Cases of HIV, Men and Women, All Ages, 2019 (N)
Figure 14: 7MM, Diagnosed Prevalent Cases of HIV, Men and Women, All Ages, 2019 (N)
Figure 15: 7MM, Age-Specific Diagnosed Prevalent Cases of HIV, Men and Women, 2019 (N)
Figure 16: 7MM, Sex-Specific Diagnosed Prevalent Cases of HIV, All Ages, 2019 (N)
Figure 17: 7MM, Diagnosed Prevalent Cases of HIV with Coinfection, Men and Women, All Ages, 2019 (N)
Figure 18: 7MM, Diagnosed Prevalent Cases of HIV on ART, Men and Women, All Ages, 2019 (N)
Figure 19: 7MM, Diagnosed Incident Cases of HIV, Men and Women, All Ages, 2019 (N)
Figure 20: 7MM, Age-Specific Diagnosed Incident Cases of HIV, Men and Women, 2019 (N)
Figure 21: 7MM, Sex-Specific Diagnosed Incident Cases of HIV, All Ages, 2019 (N)
Figure 22: 7MM, Prophylactic Population on PrEP, Men and Women, All Ages, 2019 (N)